Weiguo Ye, COO of Gyre Therapeutics GYRE, has filed 0 purchases and 16 sales on the open market. Over the past 12 months that comes to a net sale of $869.9K. The latest trade was on 06/18.

WY

WY

Weiguo Ye

COO

Company

Gyre Therapeutics GYRE

First filing

23/11/22

Trades

58 trades

Buys / sales

0 / 16

12-month net buying

−$869.9K

Last trade

06/18

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Gyre TherapeuticsGYRE	Open-market sale	06/09–06/18	06/22	11,000 sh3 trades	$6.25avg.	$68,700	−1.5%
Gyre TherapeuticsGYRE	Open-market sale	06/11	06/15	2,800 sh	$6.17	$17,276	−0.4%
Gyre TherapeuticsGYRE	Open-market sale	06/09–06/10	06/11	20,918 sh2 trades	$6.16avg.	$128,885.78	−2.9%
Gyre TherapeuticsGYRE	Open-market sale	06/04–06/05	06/08	34,976 sh2 trades	$6.25avg.	$218,561.15	−4.8%
Gyre TherapeuticsGYRE	Open-market sale	05/22–05/26	05/27	7,500 sh2 trades	$6.09avg.	$45,680	−1.1%
Gyre TherapeuticsGYRE	Open-market sale	05/20–05/21	05/22	22,220 sh2 trades	$6.15avg.	$136,653	−3.1%
Gyre TherapeuticsGYRE	Open-market sale	05/18–05/19	05/20	9,320 sh2 trades	$6.38avg.	$59,418.4	−1.3%
Gyre TherapeuticsGYRE	Open-market sale	05/14–05/15	05/18	28,680 sh2 trades	$6.79avg.	$194,772.8	−3.9%